SAMMSON is described as a pro-oncogene involved in mitochondrial homeostasis and metabolism that is expressed in aggressive melanomas, where it promotes cell growth, while its downregulation in melanoma xenografts suppressed the tumor growth, making it an important potential therapeutic target in melanoma patients [100,101]. The gene discussed is SAMMSON; the disease is melanoma.